MMSI

Merit Medical Systems, Inc. [MMSI] Stock Forecast

Q: What is Merit Medical Systems, Inc. stock symbol ?

Merit Medical Systems, Inc. is a US stock, located in South jordan of Ut and trading under the symbol MMSI

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?

MMSI Stock Summary

Earnings have grown 8.89% per last year.

EPS has been increasing for the past 3 years (Yearly statements)

EPS has been increasing for the past 3 quarters (Quarter statements)

Earnings are expected to fall -100% next year

MMSI has less than 1 year of cash runway

Top 10 Correlated ETFs

MMSI

Top 10 Correlated Stocks

MMSI

In the News

MMSI Financial details

Company Rating

Strong Buy

Market Cap

4.21B

Income

94.41M

Revenue

1.26B

Book val./share

20.8

Cash/share

10.19

Dividend

Dividend %

Employees

6.95K

Optionable

Shortable

Yes

Earnings

30 Apr 2024

P/E

44.9

Forward P/E

PEG

17.82

P/S

3.67

P/B

3.66

P/C

7.04

P/FCF

62.96

Quick Ratio

1.33

Current Ratio

3.13

Debt / Equity

0.69

LT Debt / Equity

0.68

EPS (TTM)

1.64

EPS next Y

EPS next Q

EPS this Y

25.19%

EPS next Y

EPS next 5Y

EPS last 5Y

75.32%

Revenue last 5Y

4.73%

Revenue Q/Q

2.56%

EPS Q/Q

6.67%

SMA20

-1.37%

SMA50

-8.86%

SMA100

Inst Own

81.22%

Inst Trans

0.87%

ROA

ROE

ROC

0.07%

Gross Margin

46%

Oper. Margin

10%

Profit Margin

Payout

Shs Outstand

Shs Float

Target Price

52W Range

62.58-85.62

52W High

-15.65%

52W Low

+15.65%

RSI

Rel Volume

0.2

Avg Volume

455.39K

Volume

89.13K

Perf Week

-2.54%

Perf Month

-4.65%

Perf Quarter

3.91%

Perf Half Y

8.67%

Beta

0.911

Volatility

0.65%, 1.17%

Prev Close

Price

71.7

Change

0.27%

MMSI Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2023-12-31

Metric	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31
	2.02K	2.02K	2.02K	2.02K	2.02K
Revenue per share	18.06	17.39	19.14	20.26	21.76
Net income per share	0.1	-0.18	0.86	1.31	1.64
Operating cash flow per share	1.41	2.98	2.62	2.01	2.52
Free cash flow per share	-0.07	2.09	2.12	1.22	1.88
Cash per share	0.8	1.03	1.21	1.03	10.23
Book value per share	17.25	17.29	18.52	20.15	20.87
Tangible book value per share	2.75	4.1	6.39	8.96	8.58
Share holders equity per share	17.25	17.29	18.52	20.15	20.87
Interest debt per share	9.74	8.03	5.7	4.84	14.81
Market cap	1.72B	3.08B	3.5B	4.01B	4.37B
Enterprise value	2.2B	3.46B	3.75B	4.22B	4.68B
P/E ratio	315.44	-312.62	72.19	53.84	46.34
Price to sales ratio	1.73	3.19	3.25	3.49	3.49
POCF ratio	22.1	18.62	23.76	35.1	30.14
PFCF ratio	-466.73	26.53	29.32	57.92	40.34
P/B Ratio	1.81	3.21	3.36	3.51	3.64
PTB ratio	1.81	3.21	3.36	3.51	3.64
EV to sales	2.21	3.58	3.48	3.67	3.73
Enterprise value over EBITDA	56.89	78.1	21.72	21.69	20.95
EV to operating cash flow	28.26	20.91	25.44	36.94	32.22
EV to free cash flow	-596.87	29.79	31.39	60.96	43.13
Earnings yield	0	0	0.01	0.02	0.02
Free cash flow yield	0	0.04	0.03	0.02	0.02
Debt to equity	0.55	0.45	0.3	0.23	0.69
Debt to assets	0.3	0.26	0.19	0.16	0.36
Net debt to EBITDA	12.4	8.55	1.43	1.08	1.35
Current ratio	2.5	2.32	2.04	2.4	5.45
Interest coverage	-5.29	-6.26	11.58	13.81	6.75
Income quality	14.27	-16.79	3.04	1.53	1.54
Dividend Yield	0	0	0	0	0
Payout ratio	0	-0.09	0.01	0.03	0
Sales general and administrative to revenue	0	0	0	0	0
Research and developement to revenue	0.07	0.06	0.07	0.07	0.07
Intangibles to total assets	0.45	0.44	0.41	0.38	0.3
Capex to operating cash flow	-1.05	-0.3	-0.19	-0.39	-0.25
Capex to revenue	-0.08	-0.05	-0.03	-0.04	-0.03
Capex to depreciation	-0.78	-0.46	-0.29	-0.49	-0.36
Stock based compensation to revenue	0.01	0.01	0.01	0.02	0.02
Graham number	6.2	8.31	18.96	24.38	27.75
ROIC	-0.1	-0.03	0.04	0.05	0.05
Return on tangible assets	0.01	-0.01	0.05	0.07	0.06
Graham Net	-9.51	-7.78	-5.35	-3.42	-4.17
Working capital	272.88M	244.7M	245.93M	308.44M	904.91M
Tangible asset value	151.44M	227.13M	358.79M	508.7M	493.88M
Net current asset value	-352.84M	-276.11M	-126.28M	9.52M	-14.77M
Invested capital	0.55	0.45	0.3	0.23	0.69
Average receivables	159.26M	163.25M	165.4M	175.64M	183.85M
Average payables	54.32M	52.23M	52.73M	62.06M	67.22M
Average inventory	211.62M	211.86M	209.97M	243.96M	284.93M
Days sales outstanding	61.83	59.82	58.7	56.59	55.12
Days payables outstanding	35.45	32.33	34.45	39.57	32.92
Days of inventory on hand	146.46	128.45	137.43	153.65	151.72
Receivables turnover	5.9	6.1	6.22	6.45	6.62
Payables turnover	10.3	11.29	10.6	9.22	11.09
Inventory turnover	2.49	2.84	2.66	2.38	2.41
ROE	0.01	-0.01	0.05	0.07	0.08
Capex per share	-1.48	-0.89	-0.5	-0.79	-0.64

Quarterly Fundamentals Overview

Last date of statement is 2023-12-31 for Q4

Metric	2022-12-31	2023-03-31	2023-06-30	2023-09-30	2023-12-31
	2.02K	2.02K	2.02K	2.02K	2.02K
Revenue per share	5.14	5.19	5.56	5.46	5.59
Net income per share	0.58	0.36	0.35	0.45	0.48
Operating cash flow per share	0.49	0.25	0.3	0.89	1.08
Free cash flow per share	0.27	0.03	0.2	0.74	0.94
Cash per share	1.02	1.01	1.25	1.06	10.19
Book value per share	20.04	20.43	20.92	21.32	20.8
Tangible book value per share	8.91	9.55	8.11	8.82	8.55
Share holders equity per share	20.04	20.43	20.92	21.32	20.8
Interest debt per share	4.74	4.68	7.14	6.24	14.55
Market cap	4.03B	4.24B	4.81B	3.98B	4.39B
Enterprise value	4.24B	4.45B	5.15B	4.28B	4.69B
P/E ratio	30.18	51.21	59.43	38.53	39.72
Price to sales ratio	13.74	14.25	15.04	12.63	13.58
POCF ratio	143.97	291.59	278.4	77.96	70.52
PFCF ratio	259.84	2.41K	408.31	93.73	80.61
P/B Ratio	3.52	3.62	4	3.24	3.65
PTB ratio	3.52	3.62	4	3.24	3.65
EV to sales	14.46	14.95	16.08	13.57	14.51
Enterprise value over EBITDA	75.98	86.86	91.03	68.61	79.44
EV to operating cash flow	151.48	305.93	297.78	83.77	75.38
EV to free cash flow	273.4	2.53K	436.74	100.72	86.16
Earnings yield	0.01	0	0	0.01	0.01
Free cash flow yield	0	0	0	0.01	0.01
Debt to equity	0.23	0.23	0.34	0.29	0.69
Debt to assets	0.16	0.16	0.22	0.2	0.36
Net debt to EBITDA	3.77	4.07	5.92	4.76	5.12
Current ratio	2.4	2.58	3.13	3.13	5.45
Interest coverage	14.09	13.12	7.83	7.26	5.77
Income quality	0.84	0.7	0.85	1.98	2.25
Dividend Yield	0	0	0	0	0
Payout ratio	0.01	0.08	0	0.14	0
Sales general and administrative to revenue	0	0	0	0	0
Research and developement to revenue	0.07	0.07	0.06	0.06	0.07
Intangibles to total assets	0.38	0.37	0.4	0.4	0.3
Capex to operating cash flow	-0.45	-0.88	-0.32	-0.17	-0.13
Capex to revenue	-0.04	-0.04	-0.02	-0.03	-0.02
Capex to depreciation	-0.54	-0.55	-0.22	-0.32	-0.3
Stock based compensation to revenue	0.01	0.01	0.02	0.02	0.02
Graham number	16.24	12.88	12.87	14.66	14.96
ROIC	0.02	0.01	0.01	0.02	0.01
Return on tangible assets	0.03	0.02	0.02	0.02	0.02
Graham Net	-3.4	-2.97	-4.65	-3.86	-4.16
Working capital	308.44M	341.27M	404.9M	398.19M	904.91M
Tangible asset value	508.7M	547.48M	466.82M	508.64M	493.88M
Net current asset value	9.52M	44.76M	-38.96M	6.7M	-14.77M
Invested capital	0.23	0.23	0.34	0.29	0.69
Average receivables	174.63M	182.13M	186.9M	189.41M	190.05M
Average payables	65.86M	67.05M	63.67M	55.31M	57.4M
Average inventory	256.33M	277.79M	297.76M	304.93M	303.9M
Days sales outstanding	54.74	56.2	52.86	54.48	52.69
Days payables outstanding	38.81	37.08	33.23	25.41	31.55
Days of inventory on hand	150.69	163.7	164.61	158.08	145.4
Receivables turnover	1.64	1.6	1.7	1.65	1.71
Payables turnover	2.32	2.43	2.71	3.54	2.85
Inventory turnover	0.6	0.55	0.55	0.57	0.62
ROE	0.03	0.02	0.02	0.02	0.02
Capex per share	-0.22	-0.22	-0.1	-0.15	-0.13

MMSI Frequently Asked Questions

What is Merit Medical Systems, Inc. stock symbol ?

Merit Medical Systems, Inc. is a US stock , located in South jordan of Ut and trading under the symbol MMSI

What is Merit Medical Systems, Inc. stock quote today ?

Merit Medical Systems, Inc. stock price is $71.7 today.

Is Merit Medical Systems, Inc. stock public?

Yes, Merit Medical Systems, Inc. is a publicly traded company.

Something similar

Top by Market Cap

Top Correlated ETFs

Top Correlated Stocks

Similar Market Cap

Company Profile

Volume Average 455.39K
Market Capitalization 4.21B
Employee 6.95K
CEO Mr. Fred P. Lampropoulos
Headquarters South Jordan,UT,US
IPO Date 1990-05-14
Website https://www.merit.com

Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures, primarily in cardiology, radiology, oncology, critical care, and endoscopy. The company operates in two segments, Cardiovascular and Endoscopy. It provides peripheral intervention products for the diagnosis and treatment of diseases in peripheral vessels and organs; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions. The company also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, manifold kits, and trays and packs; coated tubes and wires; and sensor components for microelectromechanical systems. In addition, it provides pulmonary products that consist of laser-cut tracheobronchial stents, over-the-wire and direct visualization delivery systems, and dilation balloons to endoscopically dilate strictures; gastroenterology products; and kits and accessories for endoscopy and bronchoscopy procedures. The company sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers in the United States and internationally. Merit Medical Systems, Inc. was incorporated in 1987 and is headquartered in South Jordan, Utah.